This announcement is a separate document:
北京植德律师事务所关于长春百克生物科技股份公司2022年限制性股票激励计划预留授予及作废部分预留限制性股票相关事项的法律意见书
Legal opinion of Beijing Zhide Law Firm on matters relating to the grant of reservations and the cancellation of some reserved restricted shares in the 2022 restricted stock incentive plan of Changchun Baike Biotechnology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.